Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS
By Jinkui Yang, Y. Feng, M. Yuan, S. Yuan, H. Fu, B. Y. Wu, G. Sun, G. Yang, X. L. Zhang, Lu Wang and 3 more. Diabetic Medicine, 2006
717 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Infectious Diseases
View Paper: https://www.semanticscholar.org/paper/62f5219df709beda2f429e5d4d276be3a720d816
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
Citations in the corpus
- Diabetes is a risk factor for the progression and prognosis of COVID‐19 (2020, neutral): “5-81] vs 23 [10-49]), as well as D-dimer (1.”
- Gender Differences in Patients With COVID-19: Focus on Severity and Mortality (2020, methodology): “We have previously reported that high protein expression of ACE2 receptor in specific organs correlated with specific organ failures, indicated by corresponding clinical parameters in SARS patients (11, 12).”
- Association of Blood Glucose Control and Outcomes in Patients with COVID-19 and Pre-existing Type 2 Diabetes (2020, background): “The percentage of known T2D history was significantly higher among patients who succumbed to SARS than who survived (Booth et al., 2003; Yang et al., 2006).”
- Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations (2020, positive): “Though there is limited data about the association of blood glucose levels with disease course in COVID-19 at present, data from other infections like SARS and influenza H1N1 has shown that patients with poor glycemic control have increased risk of complications and death [60,61].”
- Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis (2020, neutral): “Severe acute respiratory syndrome (SARS) outbreak in 202-2004 and Middle East Respiratory Syndrome (MERS) outbreaks in 2012 and 2015, had also resulted in increased severity and fatality in patients with diabetes mellitus [31] [32] [33] [34] [35] .”
- COVID-19 and diabetes: Knowledge in progress (2020, neutral): “[36] Yang JK, Feng Y, Yuan MY, Yuan SY, Fu HJ, Wu BY, et al.”
- Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes (2009, background): “In our previous report, hyperglycemia was an independent predictor of death, and patients with even mild SARS (receiving no glucocorticoid medications during the course) had a higher level of FPG [1].”